author-photo

Chrystian Dallaire

University of Calgary

12

Papers

877

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

S1051 Methotrexate for the Prevention of Antibodies to Infliximab in Patients With Crohn's Disease

2010 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (19)
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn Disease: The EPIC Randomized Controlled Trials

2008 JAMA
Show All
- Source
- Cite
- Save
Citations (224)
A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease

2008 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (76)
Extent of Disease in Mild To Moderate Ulcerative Proctitis: Comparison of 2 Mesalamine (5-ASA) Suppositories in a Randomized Trial

2005 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

2003 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (96)
A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H. pylori infection

2001 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.

2001 Canadian Journal of Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (28)
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1997 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (156)